September 6, 2022
Noted businessman and philanthropist T. Denny Sanford has committed $150 million in new funding to expand and, in some ways, quite literally launch stem cell research and regenerative medicine at University of California San Diego into new spaces and endeavors.
September 2, 2022
Using a mouse model, UC San Diego researchers describe a process in which affected neurons switch expression of neurotransmitters in response to day length stimuli, triggering related behavioral changes.
August 11, 2022
In mouse studies, UC San Diego researchers find that excess alcohol consumption alters gut microbiome but latter is not directly or significantly linked to liver disease.
August 11, 2022
This month, Brookie Best was named new dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences, succeeding James McKerrow, who stepped down in June after serving as dean for seven years.
August 10, 2022
A UC San Diego-led program that monitors wastewater for the presence of SARS-CoV-2 and which has effectively predicted subsequent surges in COVID-19 cases in San Diego has been expanded to detect the presence of monkeypox.
August 5, 2022
Researchers at University of California San Diego School of Medicine and Rady Children’s Hospital-San Diego have joined a nationwide study to better understand the long-term impact of COVID-19 on patients in the United States across all demographic groups.
August 5, 2022
Brookie Best, PharmD, has been named the next dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, succeeding James McKerrow, PhD, MD, who stepped down June 30, 2022.
August 4, 2022
UC San Diego and Salk Institute researchers report a surprising link between mitochondria, inflammation and gene mutations that may increase risk of atherosclerosis.
August 4, 2022
UC San Diego researchers report using native bacteria in mice as the chassis for delivering transgenes capable of inducing persistent and potentially even curative therapeutic changes in the gut and reversing disease pathologies.
August 2, 2022
Researchers report that a gene therapy approach, developed at UC San Diego measurably delayed disease onset in humanized mouse and rat models of familial ALS, an inherited form of the disease that runs in families.
